[Dosimetric factors related to postoperative pulmonary complications in locally advanced esophageal cancers treated with preoperative chemoradiotherapy: Literature review].

Facteurs dosimétriques liés aux complications pulmonaires postopératoires dans les cancers de l’œsophage localement avancés traités par radiochimiothérapie préopératoire : revue de la littérature.
Cancer de l’œsophage Complications postopératoires Complications pulmonaires Dosimetric factors Esophageal cancer Facteurs dosimétriques Postoperative complication Preoperative chemoradiotherapy Pulmonary complication Radiochimiothérapie préopératoire

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 04 04 2020
revised: 22 06 2020
accepted: 01 07 2020
pubmed: 27 9 2020
medline: 30 10 2020
entrez: 26 9 2020
Statut: ppublish

Résumé

Preoperative chemoradiotherapy is an option for locally advanced esophageal cancer. Radiation therapy may increase postoperative pulmonary complications. Usual lungs dose constraints in radiotherapy are old and used by extrapolation of lung cancer management. Our objective is to review the literature on correlations between postoperative lung toxicity and dosimetric factors. This literature review identified and selected studies published between 1987 and 2019 using the PRISMA method. The articles were identified on the basis of a PubMed search and the author's knowledge, using the following terms: "esophageal cancer"; "chemoradiotherapy"; "dosimetric factors"; "postoperative pulmonary complications". Fourteen articles were selected, and five did not demonstrate a correlation between dosimetric factors and the postoperative pulmonary complications rate. The V20 (lung volume receiving more than 20Gy) was identified in three studies, like the V10, V15 and mean lung dose (around 10Gy) in two studies. The V30≥20% was identified in one study. The most frequently identified dosimetric predictors for postoperative pulmonary complications are the V20 and the mean lung dose. Results of prospective studies would lead us to specify which of these parameters is most relevant for predicting the risk of postoperative pulmonary complications.

Identifiants

pubmed: 32977935
pii: S0007-4551(20)30344-1
doi: 10.1016/j.bulcan.2020.07.001
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

982-990

Informations de copyright

Copyright © 2020 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Marie Dworczak (M)

Centre Oscar-Lambret, département universitaire de radiothérapie, 3, rue F.-Combemale, 59020 Lille, France. Electronic address: marie.dworczak@gmail.com.

Marie-Cécile Le Deley (MC)

Centre Oscar-Lambret, département de méthodologie et biostatistiques, 3, rue F.-Combemale, 59020 Lille, France.

Antoine Adenis (A)

Institut du cancer de Montpellier, département d'oncologie médicale, 208, avenue des Apothicaires, 34298 Montpellier, France; Université Montpellier, IRCM, ICM, Inserm, Montpellier, France.

Guillaume Piessen (G)

Hôpital Claude-Huriez, service de chirurgie digestive et oncologique, rue M.-Polonowski, 59000 Lille, France.

Éric Lartigau (É)

Centre Oscar-Lambret, département universitaire de radiothérapie, 3, rue F.-Combemale, 59020 Lille, France; Université de Lille, CRIStAL UMR 9189, Lille, France.

Xavier Mirabel (X)

Centre Oscar-Lambret, département universitaire de radiothérapie, 3, rue F.-Combemale, 59020 Lille, France.

Thomas Lacornerie (T)

Centre Oscar-Lambret, département de physique médicale, 3, rue F.-Combemale, 59020 Lille, France.

David Pasquier (D)

Centre Oscar-Lambret, département universitaire de radiothérapie, 3, rue F.-Combemale, 59020 Lille, France; Université de Lille, CRIStAL UMR 9189, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH